Volume 48, Issue 6, Pages (December 2005)

Slides:



Advertisements
Similar presentations
Volume 70, Issue 4, Pages (May 2011)
Advertisements

Volume 26, Issue 17, Pages (September 2016)
Volume 77, Issue 2, Pages (January 2013)
Volume 49, Issue 4, Pages (February 2006)
Steven A. Sloan, Ben A. Barres  Neuron 
Regulation of Presynaptic Neurotransmission by Macroautophagy
APP Processing and Synaptic Function
Volume 79, Issue 3, Pages (August 2013)
ApoE Promotes the Proteolytic Degradation of Aβ
Endocannabinoids Control the Induction of Cerebellar LTD
Role of Glutamate Autoreceptors at Hippocampal Mossy Fiber Synapses
Volume 56, Issue 1, Pages (October 2007)
Volume 81, Issue 4, Pages (February 2014)
A Role of Intracellular Na+ in the Regulation of Synaptic Transmission and Turnover of the Vesicular Pool in Cultured Hippocampal Cells  Alexandre Bouron,
A Kainate Receptor Increases the Efficacy of GABAergic Synapses
Volume 55, Issue 4, Pages (August 2007)
Volume 8, Issue 2, Pages (July 2014)
Volume 58, Issue 4, Pages (May 2008)
Volume 60, Issue 2, Pages (October 2008)
Liang Yang, Yong Qi, Yunlei Yang  Cell Reports 
Volume 78, Issue 1, Pages (April 2013)
Volume 80, Issue 4, Pages (November 2013)
Volume 58, Issue 1, Pages (April 2008)
Volume 74, Issue 6, Pages (June 2012)
Yildirim Sara, Tuhin Virmani, Ferenc Deák, Xinran Liu, Ege T. Kavalali 
Heterosynaptic LTD of Hippocampal GABAergic Synapses
CDK5 Serves as a Major Control Point in Neurotransmitter Release
Volume 15, Issue 1, Pages (January 2012)
Jianrong Tang, John A. Dani  Neuron 
Volume 144, Issue 5, Pages (March 2011)
ApoE4 Accelerates Early Seeding of Amyloid Pathology
Volume 26, Issue 17, Pages (September 2016)
Volume 77, Issue 2, Pages (January 2013)
Volume 78, Issue 4, Pages (May 2013)
Volume 83, Issue 2, Pages (July 2014)
Volume 23, Issue 1, Pages (April 2018)
Nobutake Hosoi, Matthew Holt, Takeshi Sakaba  Neuron 
Volume 68, Issue 5, Pages (December 2010)
Volume 50, Issue 2, Pages (April 2006)
Volume 46, Issue 6, Pages (June 2005)
Volume 90, Issue 3, Pages (May 2016)
Volume 82, Issue 2, Pages (April 2014)
Volume 71, Issue 5, Pages (September 2011)
Volume 123, Issue 1, Pages (October 2005)
Volume 50, Issue 2, Pages (April 2006)
Dario Brambilla, David Chapman, Robert Greene  Neuron 
Zhenglin Gu, Jerrel L. Yakel  Neuron 
Volume 64, Issue 5, Pages (December 2009)
Volume 126, Issue 4, Pages (August 2006)
Volume 52, Issue 4, Pages (November 2006)
Kentaro Abe, Masatoshi Takeichi  Neuron 
Volume 82, Issue 1, Pages (April 2014)
Volume 44, Issue 4, Pages (November 2004)
Volume 125, Issue 4, Pages (May 2006)
Matthew E. Klein, Pablo E. Castillo, Bryen A. Jordan  Cell Reports 
Volume 16, Issue 11, Pages (September 2016)
Stephanie Rudolph, Linda Overstreet-Wadiche, Jacques I. Wadiche  Neuron 
Volume 52, Issue 2, Pages (October 2006)
Strong G-Protein-Mediated Inhibition of Sodium Channels
Dopamine-Dependent Interactions between Limbic and Prefrontal Cortical Plasticity in the Nucleus Accumbens: Disruption by Cocaine Sensitization  Yukiori.
Karen M. Crosby, Wataru Inoue, Quentin J. Pittman, Jaideep S. Bains 
Leptin Regulation of the Mesoaccumbens Dopamine Pathway
Volume 51, Issue 4, Pages (August 2006)
Yildirim Sara, Tuhin Virmani, Ferenc Deák, Xinran Liu, Ege T. Kavalali 
Volume 90, Issue 3, Pages (May 2016)
Volume 71, Issue 5, Pages (September 2011)
ApoE and Clusterin Cooperatively Suppress Aβ Levels and Deposition
Volume 39, Issue 1, Pages (July 2003)
Volume 71, Issue 1, Pages (July 2011)
Volume 23, Issue 12, Pages (December 2016)
Presentation transcript:

Volume 48, Issue 6, Pages 913-922 (December 2005) Synaptic Activity Regulates Interstitial Fluid Amyloid-β Levels In Vivo  John R. Cirrito, Kelvin A. Yamada, Mary Beth Finn, Robert S. Sloviter, Kelly R. Bales, Patrick C. May, Darryle D. Schoepp, Steven M. Paul, Steven Mennerick, David M. Holtzman  Neuron  Volume 48, Issue 6, Pages 913-922 (December 2005) DOI: 10.1016/j.neuron.2005.10.028 Copyright © 2005 Elsevier Inc. Terms and Conditions

Figure 1 Modulating Neuronal Activity via the Perforant Pathway Alters ISF Aβ Levels (A) Representative traces of basal EEG activity (top) and epileptiform discharges during electrical stimulation of the perforant pathway (bottom) in 3- to 5-month-old Tg2576 mice. (B) When EEG activity was elevated, ISF Aβ levels increased by 133.3% ± 19.7% (p = 0.05; n = 5). (C) LY354740 (30 μM), a selective mGluR2/3 agonist, was administered into the hippocampus via reverse microdialysis to inhibit glutamate release from the perforant pathway, causing ISF Aβ levels to significantly decrease to 81.8% ± 4.9% (p = 0.0181) of baseline after 12 hr. This is consistent with decreased neurotransmission from the perforant pathway leading to decreased ISF Aβ levels. Data represent mean ± SEM. Neuron 2005 48, 913-922DOI: (10.1016/j.neuron.2005.10.028) Copyright © 2005 Elsevier Inc. Terms and Conditions

Figure 2 Inhibiting Neuronal Activity Decreases ISF Aβ Levels (A) Representative traces of basal hippocampal EEG activity (top) and 16 hr following the onset of continuous 5 μM TTX administration via reverse microdialysis into the hippocampus (bottom). EEG amplitude was substantially decreased in the presence of TTX. (B) EEG activity remained relatively constant prior to TTX treatment but gradually declined during the first 30 min of administration and reached negligible levels by 16 hr (p < 0.0001). (C) As EEG activity declined, ISF Aβ1–x levels declined as well, reaching 70.4% ± 4.5% of baseline at 16 hr (p < 0.0001; n = 5). (D) When EEG activity and ISF Aβ levels at each time point within the same mouse were compared, there was a highly significant correlation (Pearson's r = 0.6619; p < 0.0001), further emphasizing the association between these measures. (E and F) TTX (1 μM) was transiently administered for 4 hr, causing both EEG activity (E) and ISF Aβ levels (F) to decline; however, when TTX was removed from the microdialysis perfusion buffer, both of these measures returned to baseline within 5 hr (n = 4). (G) Prior to and during TTX washout, EEG activity and Aβ levels remained strongly correlated (Pearson's r = 0.4935; p < 0.0001). Data represent mean ± SEM. Neuron 2005 48, 913-922DOI: (10.1016/j.neuron.2005.10.028) Copyright © 2005 Elsevier Inc. Terms and Conditions

Figure 3 Synaptic Activity Regulates ISF Aβ Levels Tetanus toxin (0.2 μg) was injected directly into the hippocampus surrounding the microdialysis probe to inhibit synaptic vesicle release. By 18 hr following treatment, EEG activity only declined by 8.2% ± 1.2% (p = 0.0061) (A), whereas ISF Aβ levels declined by 61.8% ± 5.3% (B) compared to baseline (p = 0.0003; n = 4). Data represent mean ± SEM. Neuron 2005 48, 913-922DOI: (10.1016/j.neuron.2005.10.028) Copyright © 2005 Elsevier Inc. Terms and Conditions

Figure 4 Depressed Synaptic Activity Alters APP Processing, Not ISF Aβ Elimination (A) ISF Aβ half-life was assessed in Tg2576 mice pretreated with vehicle or 1 μM TTX. After 8 hr of TTX treatment, when Aβ levels reached a new steady-state level, animals were injected with 3 mg/kg of LY411575, a potent γ-secretase inhibitor. ISF Aβ levels were sampled at 30 min intervals following treatment. After 4 hr, ISF Aβ levels were less than 10% of the new baseline of each group (n = 4–5 per group). (B) The elimination of ISF Aβ followed first-order kinetics, and the half-life of Aβ was nearly identical in mice treated with vehicle and TTX: 0.93 ± 0.085 hr and 1.06 ± 0.073 hr, respectively (n = 4–5 per group). To determine if TTX altered expression of the Aβ-degrading enzyme neprilysin, Tg2576 mice were treated by reverse microdialysis with 1 μM TTX for 16 hr, followed by microdissection of the treated hippocampus. Each hippocampus was processed for Western blot analysis, and the level of neprilysin was assessed (n = 7 per group). Each band was normalized to the amount of tubulin in each lane. (C) The level of neprilysin was the same in vehicle- and TTX-treated mice. (D) Representative lanes from Western blot. To determine if APP processing was altered in the presence of TTX, the same tissues were also assessed for the levels of full-length APP (FL-APP), α-CTF, and β-CTF (n = 7 per group). (E) FL-APP and β-CTF did not change after TTX treatment; however, there was a significant increase in α-CTF (p = 0.007), suggesting that inhibition of neuronal activity alters APP processing. (F) Representative lanes from Western blot. Data represent mean ± SEM. Neuron 2005 48, 913-922DOI: (10.1016/j.neuron.2005.10.028) Copyright © 2005 Elsevier Inc. Terms and Conditions

Figure 5 Extracellular Aβ Levels Are Directly Linked to Synaptic Vesicle Exocytosis Acute brain slices were made from 4- to 5-week-old wild-type (B6/SJL) or Tg2576 mice. (A) To determine if extracellular Aβ is actively eliminated by the slice, 300 pg/ml of exogenous human Aβ was added to culture chambers containing either no tissue or brain slices from wild-type mice. Over 12 hr, Aβ levels declined by 11.0% ± 3.0% compared to the initial collection regardless of whether tissue was present in the chamber or not (n = 5 per group). (B) Brain slices from Tg2576 mice were incubated with several concentrations of LY411575, a γ-secretase inhibitor. At 10 nM and 100 nM, Aβ levels decreased significantly by 53.1% ± 6.6% and 66.4% ± 3.7%, respectively, as compared to untreated slices (n = 6 per group). (C) Slices from Tg2576 mice were stimulated with 25 mM KCl or inhibited with 100 nM TTX for 12 hr, resulting in 27.3% ± 4.2% more and 24.2% ± 6.9% less extracellular Aβ, respectively, than untreated slices over 12 hr (n = 6 per group). (D) To determine the effect of synaptic vesicle exocytosis on extracellular Aβ levels in the absence of synaptic activity, Tg2576 brain slices were cultured for 2 hr in the presence of 0.5 nM α-latrotoxin and/or a cocktail of activity inhibitors including 100 nM TTX, 10 μM NBQX, and 50 μM APV. α-latrotoxin alone caused a 35% ± 6.9% increase in Aβ levels, whereas the inhibitor cocktail lowered Aβ levels by 18.0% ± 4.1% compared to untreated slices. α-latrotoxin plus the inhibitor cocktail resulted in 13.3% more extracellular Aβ as compared to untreated slices and 38.3% ± 6.2% more Aβ compared to the inhibitor cocktail alone (n = 12–15 per group). At the conclusion of each experiment, brain slices were washed with PBS and processed for Western blot analysis of APP-CTF. (E) Neither the level of α-CTF nor the level of β-CTF changed over the 2 hr culture period. (F) Representative lanes from Western blot. Data represent mean ± SEM. Neuron 2005 48, 913-922DOI: (10.1016/j.neuron.2005.10.028) Copyright © 2005 Elsevier Inc. Terms and Conditions